Comparing the effect of Drinking and Inhaling of Pushkaramoola distillate for better breathing and Asthma relief.

A comparative clinical study to evaluate the effect of Pana and Nebulization of Pushkaramoola Arka in Pulmonary Function and the symptoms of Bronchial Asthma. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070713

Enrollment

Registered

2024-07-16

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J40-J47- Chronic lower respiratory diseases Health Condition 2: J454- Moderate persistent asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects of age group 18-60 years irrespective of their gender and socio-economic status. 2. Subjects with well and partially controlled Bronchial Asthma (as per Global initiative for Asthma, Guideline 2023) 3. Subjects with intermittent and mild persistent controlled Bronchial Asthma (FEV1/FVC between 50% to 79%) 4. Subjects agreeing to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Subjects with acute exacerbation 2. Subjects who need rescue medication (e.g., Salbutamol inhaler, etc.) 3. Subjects with evidence of requirement of intubations for Asthma or has been hospitalized for Asthma within one month before the study commences. 4. Subjects with evidence of malignancy and cardiovascular disease 5. Subjects with other respiratory disorders like Interstitial Lung Disease, Bronchiectasis, COPD, Tuberculosis, Cystic Fibrosis. 6. Airway obstruction from mass or foreign body 7. Autoimmune disease like Rheumatoid and Sero-Negative Arthritis 8. Smokers 9. Pregnant or lactating women

Design outcomes

Primary

Measure	Time frame
Compare the effect of Pana and nebulization in PFT and symptoms of Bronchial Asthma. Study the effect of Pushkaramoola Arka Pana 12ml twice daily after food for in PFT and symptoms of Bronchial Asthma. Study the effect of Pushkaramoola Arka nebulization 3ml for 10 minutes for in PFT and symptoms of Bronchial Asthma. (Subjective parameter) 1)Asthma Control Questionnaire 2)Asthma Quality of Life Questionnaire (Objective parameter) Spirometry (FEV1, FVC, FEV1/FVC, PEF),TC,DC, ESR, AEC Timepoint: Subjective and Objective parameter will be assessed on 0th day, 2week(15th day),4 week( 29th day)	—

Measure

Time frame

Compare the effect of Pana and nebulization in PFT and symptoms of Bronchial Asthma. Study the effect of Pushkaramoola Arka Pana 12ml twice daily after food for in PFT and symptoms of Bronchial Asthma. Study the effect of Pushkaramoola Arka nebulization 3ml for 10 minutes for in PFT and symptoms of Bronchial Asthma. (Subjective parameter) 1)Asthma Control Questionnaire 2)Asthma Quality of Life Questionnaire (Objective parameter) Spirometry (FEV1, FVC, FEV1/FVC, PEF),TC,DC, ESR, AEC Timepoint: Subjective and Objective parameter will be assessed on 0th day, 2week(15th day),4 week( 29th day)

—

Secondary

Measure	Time frame
1. To assess the safety of Pushkaramoola Arka Pana 12ml twice daily after food 2. To assess the safety of Pushkaramoola Arka nebulization 3ml for 10 minutes Safety Parameters are, Liver Function Test Renal Function Test Blood Routine with erythrocyte Sedimentation Rate will be done to assess the safety. Timepoint: safety parameters will be assessed on 0th & 2 week(15th day).	—

Countries

India

Contacts

Public ContactAngel Grace Chacko

Pankajakasthuri Ayurveda Medical College and PG Centre

angelgracechacko@gmail.com8921428248

Outcome results